Skip to content

Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02777346
Enrollment
550
Registered
2016-05-19
Start date
2016-05-31
Completion date
2025-02-06
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and Injuries

Keywords

WOUNDS, PENETRATING, CHILD, PRESCHOOL, CHILD, INFANT, ADOLESCENT, SUTURES, POLYGLACTIN 910, POLYPROPYLENES

Brief summary

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization. Outcomes are: 1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol) 2. scar appearance at a 6-months follow-up.

Detailed description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization. After obtaining the patient's/parent's consent and randomization, the suture material will be provided. Selection of the size of the thread and the date of the first follow-up are determined as follows: * Face: Thread size 5-0 to 7-0, first follow-up 4-7 days * Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days * Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days * Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days * Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators. Outcomes: 1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol) 2. scar appearance at a 6-months follow-up.

Interventions

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups. Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

DEVICENon absorbable

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups. Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

Sponsors

Pediatric Clinical Research Platform
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
1 Days to 16 Years
Healthy volunteers
No

Inclusion criteria

* Patient younger than 16 years of age with a wound requiring suture

Exclusion criteria

* Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.) * Wounds with tissue loss * Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.) * Wounds caused by animal or human bites * Sutures not performed in the emergency room * Heavily soiled wounds

Design outcomes

Primary

MeasureTime frameDescription
Short-term infection risk4 to 21 daysScars classified as no evidence of infection, signs of inflammation and signs of active infection

Secondary

MeasureTime frameDescription
Scar appearance6 monthsScoring based on the Manchester scar scale

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026